Abstract

Neutrophils act as the first line of defense during infection and inflammation. Once activated, they are able to fulfil numerous tasks to fight inflammatory insults while keeping a balanced immune response. Besides well-known functions, such as phagocytosis and degranulation, neutrophils are also able to release “neutrophil extracellular traps” (NETs). In response to most stimuli, the neutrophils release decondensed chromatin in a NADPH oxidase-dependent manner decorated with histones and granule proteins, such as neutrophil elastase, myeloperoxidase, and cathelicidins. Although primarily supposed to prevent microbial dissemination and fight infections, there is increasing evidence that an overwhelming NET response correlates with poor outcome in many diseases. Lung-related diseases especially, such as bacterial pneumonia, cystic fibrosis, chronic obstructive pulmonary disease, aspergillosis, influenza, and COVID-19, are often affected by massive NET formation. Highly vascularized areas as in the lung are susceptible to immunothrombotic events promoted by chromatin fibers. Keeping this fragile equilibrium seems to be the key for an appropriate immune response. Therapies targeting dysregulated NET formation might positively influence many disease progressions. This review highlights recent findings on the pathophysiological influence of NET formation in different bacterial, viral, and non-infectious lung diseases and summarizes medical treatment strategies.

Highlights

  • The lung comprises different mucosal and alveolar compartments harboring resident immune cells maintaining a well-balanced milieu of protection versus potentially infectious inhaled pathogens

  • Long persisting S. aureus has been shown to be able to adapt to neutrophil-rich environments by increasing nuclease expression to evade neutrophil extracellular traps (NETs) killing, as it was demonstrated in airway isolates of cystic fibrosis patients [139]

  • The authors in this study showed that treatment with sialidase or the use of P. aeruginosa strains lacking sialic acids led to increased NET production compared with sialic acidpositive strains

Read more

Summary

Introduction

The lung comprises different mucosal and alveolar compartments harboring resident immune cells maintaining a well-balanced milieu of protection versus potentially infectious inhaled pathogens. NETs are able to promote vaso-occlusion, initiated by the hypoxia-induced release of von Willebrand factor (VWF) and endothelial P-selectin, resulting in neutrophil recruitment and activation [35,36]. Another proposed mechanism is the P-selectin-dependent neutrophil and platelet recruitment. In vitro experiments with human monocyte-derived macrophages and PMA-stimulated human neutrophils demonstrated that macrophages are able to internalize NETs in a cathelicidin LL37-dependent manner and degrade DNA via TREX1/DNAseIII. In this setting, DCs contribute to extracellular. This review focuses on the role of NET formation during virus-induced lung infections, as well as primary and secondary bacterial infections, and summarizes possible therapeutic interventions

The Role of NETs in Virus-Induced Lung Diseases
COVID-19
Respiratory Syncitial Virus
Influenza
The Role of NETs in Bacteria-Associated Lung Diseases
Streptococcus Pneumoniae
Staphylococcus Aureus
Cystic Fibrosis and Pseudomonas Aeruginosa
Chronic Obstructive Pulmonary Disease
Pathogenic Fungal Lung Infection—Aspergillosis
NET-Targeting Therapies
DNase1
Histones
Neutrophil Elastase
Other Treatments
Summary
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call